Episode Player
Insights from JP Morgan 2026 with Liz Fowler, PhD, JD
AVBCC Value-Based Voices
Chapters
1:13
Insights from JP Morgan Healthcare Conference
3:46
Government's Role in Healthcare Policy
8:06
Drug Pricing and Market Dynamics
11:53
Site Neutrality and Reimbursement Challenges
15:58
340 B Drug Pricing
20:02
Building Relationships in Healthcare Policy
22:06
AI and What it Holds for Healthcare
AVBCC Value-Based Voices
Insights from JP Morgan 2026 with Liz Fowler, PhD, JD
Feb 07, 2026
Season 1
Episode 1
Rachael
Commercial health plans may have been missing from J.P. Morgan 2026, but government had a big presence! Value-Based Voices host Burt Zweigenhaft, PhD, and nationally recognized health policy expert Liz Fowler, PhD, JD, share their observations from this year’s meeting and key insights around most-favored nation prescription drug pricing, 340B, PBMs, Medicare site neutrality, AI, and of course value-based care.
Contact Value-Based Voices
- Follow AVBCC on LinkedIn
- View our podcast lineup
- Contact us at info@avbcc.org
Thanks for listening!
